Ross Breckenridge, PHD, MD

Dr Breckenridge trained in medicine at Cambridge University, UK, where he was also awarded a PhD. He went on to train as a Clinical Pharmacologist at University College London. After a successful career as a clinician scientist in the UK NHS, became the CEO of Silver Creek Pharmaceuticals, San Francisco, in 2016. In 2018 he returned to Europe to found Arjuna Therapeutics.